the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
Conditions: Non-small Cell Lung Cancer Interventions: Drug: Trilaciclib Sponsors: Henan Cancer Hospital; Jiangsu Simcere Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions
Conditions: Pancreatic Cancer; Endoscopic Ultrasound; Radiofrequency Ablation Interventions: Procedure: ex-vivo RFA under US control at 10 Watts (W) of power in 3 differents arms of lesions; Procedure: ex-vivo RFA under US control at 30 Watts (W) of power in 3 differents arms of lesions; Procedure: ex-vivo RFA under US control at 50 Watts (W) of power in 3 differents arms of lesions Sponsors: IRCCS San Raffaele Terminated (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC
Conditions: Intrahepatic Cholangiocarcinoma Interventions: Radiation: Radiotherapy; Drug: HAIC (GEMOX); Drug: Chemotherapy Sponsors: Shandong Cancer Hospital and Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
Conditions: Advanced Hepatocellular Carcinoma Interventions: Drug: HAIC+Serplulimab （HLX10）+ Bevacizumab Biosimilar（HLX04） Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
Conditions: Pancreatic Cancer Interventions: Drug: JS001; Drug: JS004; Drug: JS007; Drug: JS015; Drug: Irinotecan Liposome Injection; Drug: 5-Fluorouracil (5-FU); Drug: Leucovorin (LV); Drug: Nab paclitaxel; Drug: Gemcitabine Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
Conditions: Cancer Pain; Nutrition Disorders Interventions: Drug: transdermal fentanyl Sponsors: Chongqing University Cancer Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery
Conditions: Liver Cancer; Renal Cancer; Rectal Cancer Interventions: Procedure: Robotic telesurgery; Procedure: Laparoscopic surgery Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab
Conditions: Early Breast Cancer; Triple Negative Breast Cancer Interventions: Drug: Pembrolizumab injection Sponsors: Fundacao Champalimaud Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Collection of Biological Specimens and Associated Health Information
Conditions: Cancer; Other Disease Sponsors: Ovation.io, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
The Effectiveness of Bupivacaine and Bupivacaine+Dexmedetomidine Combination in Transversus Abdominis Plane* Block
Conditions: Colorectal Cancer; Colorectal Neoplasms Interventions: Drug: Bupivacain; Drug: bupivacain+dexmedetomidine Sponsors: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
A Study Collecting Health Information to Understand and Prevent Gastric Cancer
Conditions: Gastric Atrophy; Gastric Intestinal Metaplasia; Dysplasia; Gastric Adenocarcinoma; Gastric Cancer Interventions: Behavioral: Questionnaire Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Breast Cancer and Breast Self-examination Education
Conditions: Breast Cancer; Breast Self-Examination Interventions: Behavioral: Education based on breast cancer and breast examination Sponsors: Sakarya University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Program of Health Behaviour Against to Cancer (PHeBAC)
Conditions: Cancer Prevention; Health Behavior; Disability, Intellectual; Parents; Cancer Screening; Experimental Study Designs; Mothers; Disabilities Mental Interventions: Behavioral: PHeBAC; Behavioral: Control Group Sponsors: Akdeniz University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer
Conditions: Oligometastatic Prostate Carcinoma; Prostate Adenocarcinoma Interventions: Drug: Abiraterone Acetate; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Biological: Gonadotropin-releasing Hormone Analog; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Other: Questionnaire Administration; Radiation: Radiation Therapy Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011
Conditions: Metastatic Breast Cancer Interventions: Diagnostic Test: 68Ga-NOTA-ABSCINT-HER2 PET/CT Sponsors: ABSCINT NV/SA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
